Preparation and Characterization of Amorphous Solid Dispersions for the Solubilization of Fenretinide
暂无分享,去创建一个
[1] Jie Zhang,et al. The antisolvent coprecipitation method for enhanced bioavailability of poorly water-soluble drugs. , 2022, International journal of pharmaceutics.
[2] C. Brullo,et al. Synthesis and Characterization of Pyrazole-Enriched Cationic Nanoparticles as New Promising Antibacterial Agent by Mutual Cooperation , 2022, Nanomaterials.
[3] S. Alfei,et al. Successful Dendrimer and Liposome-Based Strategies to Solubilize an Antiproliferative Pyrazole Otherwise Not Clinically Applicable , 2022, Nanomaterials.
[4] Kinam Park,et al. Evolution of drug delivery systems: From 1950 to 2020 and beyond. , 2021, Journal of controlled release : official journal of the Controlled Release Society.
[5] Yongchao Su,et al. Optimizing Solvent Selection and Processing Conditions to Generate High Bulk-Density, Co-Precipitated Amorphous Dispersions of Posaconazole , 2021, Pharmaceutics.
[6] S. Alfei,et al. Considerable Improvement of Ursolic Acid Water Solubility by Its Encapsulation in Dendrimer Nanoparticles: Design, Synthesis and Physicochemical Characterization , 2021, Nanomaterials.
[7] Lynne S. Taylor,et al. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies , 2021, Acta pharmaceutica Sinica. B.
[8] S. Alfei,et al. Synthesis of Polystyrene-Based Cationic Nanomaterials with Pro-Oxidant Cytotoxic Activity on Etoposide-Resistant Neuroblastoma Cells , 2021, Nanomaterials.
[9] S. Alfei,et al. D-α-Tocopherol-Based Micelles for Successful Encapsulation of Retinoic Acid , 2021, Pharmaceuticals.
[10] S. Groshen,et al. A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors , 2021, Cancer Chemotherapy and Pharmacology.
[11] Sonal V. Bhujbal,et al. Physical Stability and Dissolution of Lumefantrine Amorphous Solid Dispersions Produced by Spray Anti-Solvent Precipitation , 2020, Journal of pharmaceutical sciences.
[12] D. Mudie,et al. A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets , 2020, International journal of pharmaceutics: X.
[13] M. Zucchetti,et al. A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells , 2019, Journal of experimental & clinical cancer research : CR.
[14] P. Oliveri,et al. Assessment of the Efficiency of a Nanospherical Gallic Acid Dendrimer for Long‐Term Preservation of Essential Oils: An Integrated Chemometric‐Assisted FTIR Study , 2019, ChemistrySelect.
[15] Christian Celia,et al. Mathematical Modeling of Release Kinetics from Supramolecular Drug Delivery Systems , 2019, Pharmaceutics.
[16] Wei Wu,et al. Development of carrier-free nanocrystals of poorly water-soluble drugs by exploring metastable zone of nucleation , 2018, Acta pharmaceutica Sinica. B.
[17] R. Williams,et al. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update. , 2018, International journal of pharmaceutics.
[18] S. Alfei,et al. Synthesis and characterization of polyester-based dendrimers containing peripheral arginine or mixed amino acids as potential vectors for gene and drug delivery , 2017, Macromolecular Research.
[19] S. Alfei,et al. Synthesis and NMR characterization of dendrimers based on 2, 2-bis-(hydroxymethyl)-propanoic acid (bis-HMPA) containing peripheral amino acid residues for gene transfection , 2017 .
[20] C. Reynolds,et al. Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives , 2017, Experimental biology and medicine.
[21] Shrawan Baghel,et al. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs. , 2016, Journal of pharmaceutical sciences.
[22] C. Wischke,et al. Design of Controlled Release PLGA Microspheres for Hydrophobic Fenretinide. , 2016, Molecular pharmaceutics.
[23] Yan He,et al. Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development. , 2015, Journal of pharmaceutical sciences.
[24] Grace A. Ledet,et al. Preparation and in vitro evaluation of hydrophilic fenretinide nanoparticles. , 2015, International journal of pharmaceutics.
[25] S. Groshen,et al. Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium , 2013, Pediatric blood & cancer.
[26] D. Ribatti,et al. Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[27] D. J. Phillips,et al. Overcoming sink limitations in dissolution testing: a review of traditional methods and the potential utility of biphasic systems , 2012, The Journal of pharmacy and pharmacology.
[28] Gert Fricker,et al. Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement. , 2012, International journal of pharmaceutics.
[29] M. Falconi,et al. Novel micelles based on amphiphilic branched PEG as carriers for fenretinide. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[30] M. Cazzaniga,et al. Fenretinide (4-HPR): A Preventive Chance for Women at Genetic and Familial Risk? , 2012, Journal of biomedicine & biotechnology.
[31] A. Naranjo,et al. Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group , 2011, Clinical Cancer Research.
[32] I. Orienti,et al. Improvement of aqueous solubility of fenretinide and other hydrophobic anti-tumor drugs by complexation with amphiphilic dextrins , 2009, Drug delivery.
[33] K. Bicknell,et al. Effect of acyl chain length on transfection efficiency and toxicity of polyethylenimine. , 2009, International journal of pharmaceutics.
[34] Yu Cao,et al. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug. , 2008, Molecular pharmaceutics.
[35] R. Gotti,et al. Fenretinide-polyvinylalcohol conjugates: new systems allowing fenretinide intravenous administration. , 2007, Biomacromolecules.
[36] E. Mileo,et al. Amphiphilic poly(vinyl alcohol) derivatives as complexing agents for fenretinide. , 2006, Biomacromolecules.
[37] J. Breitenbach. Melt extrusion: from process to drug delivery technology. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[38] S. K. Bhaumik,et al. Adsorption behaviour of polyvinyl pyrrolidone on oxide surfaces , 2000 .
[39] M. Sporn,et al. Relationships between structure and activity of retinoids , 1976, Nature.
[40] Wagh Vinod Tukaram. Solid Dispersions as Strategy to Improve Oral Bioavailability of Poor Water Soluble Drugs , 2013 .
[41] R. Saudagar,et al. ON SOLUBILITY ENHANCEMENT TECHNIQUES , 2013 .
[42] F. Seel. Grundlagen der analytischen Chemie , 1970 .